Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Octavio Castanos
Regulatory Coordinator II
Cancer Center Division
Full Page
Overview
Research
More
Collaboration
(4)
Clara Curiel
Mutual work: 1 Grant﹒1 Proposal
Collaboration Details
Edward Gelmann
Mutual work: 1 Grant﹒1 Proposal
Collaboration Details
Brianna Denton
Mutual work: 2 Proposals﹒1 Supervisor﹒1 Grant
Collaboration Details
Lizeth Evangelista
Mutual work: 4 Grants﹒5 Proposals
Collaboration Details
Grants
(9)
EMBER-4: A Randomized, Open-Label, Phase 3 Study of Adjuvant Imlunestrant Vs Standard Adjuvant Endocrine Therapy in Patients Who Have Previously Received 2 to 5 Years of Adjuvant Endocrine Therapy for
Active
·
2024
·
$0 / $556.9K
·
External
breast cancer,
adjuvant therapy,
immunotherapy,
clinical trial,
hormone receptor
A Phase 3 Randomized, Open-label Study Of Op-1250 Monotherapy Vs Standard Of Care For The Treatment Of Er+, Her2- Advanced Or Metastatic Breast Cancer Following Endocrine And Cdk 4/6 Inhibitor Therapy
Active
·
2024
·
$0 / $512.6K
·
External
breast cancer,
cancer treatment,
monotherapy,
endocrine therapy
A Phase 1/2 Open-Label, Multicenter, Global Trial to Characterize the Safety, Tolerability and Preliminary Efficacy of CFT1946 as a Monotherapy and in Combination with Trametinib in Subjects with BRAF
Active
·
2024
·
$0 / $433.9K
·
External
drug development,
oncology,
clinical trials,
pharmacology,
precision medicine
A Post-market Multi-center Prospective Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss in Women Receiving Specific Chemotherapy Regimens for Breast Cancer
Active
·
2024
·
$0 / $120.6K
·
External
oncology,
chemotherapy,
hair loss,
clinical trial
MammaPrint, BluePrint, and Full-genome Data Linked with Clinical Data to Evaluate New Gene Expression Profiles: An Adaptable Registry (FLEX Registry)
Active
·
2024
·
$0 / $39.1K
·
External
gene expression,
registry data,
genomic data analysis,
cancer research
Page 1 of 2
Previous page
Next page
